检索结果 - Takahiro Araki

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Randomized, Double-Blind, Dose-Ranging Study of TAK-875, a Novel GPR40 Agonist, in Japanese Patients With Inadequately Controlled Type 2 Diabetes

    Randomized, Double-Blind, Dose-Ranging Study of TAK-875, a Novel GPR40 Agonist, in Japanese Patients With Inadequately Controlled Type 2 Diabetes 由 Kohei Kaku, Takahiro Araki, Ryoji Yoshinaka

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study

    Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study 由 Yoshikazu Kinoshita, Yuuichi Sakurai, Nobuyoshi Takabayashi, Kentarou Kudou, Takahiro Araki, Takuya Miyagi, Katsuhiko Iwakiri, Kiyoshi Ashida

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Association of Serum Fetuin-A With Insulin Resistance in Type 2 Diabetic and Nondiabetic Subjects

    Association of Serum Fetuin-A With Insulin Resistance in Type 2 Diabetic and Nondiabetic Subjects 由 Katsuhito Mori, Masanori Emoto, Hisayo Yokoyama, Takahiro Araki, Megumi Teramura, Hidenori Koyama, Tetsuo Shoji, Masaaki Inaba, Yoshiki Nishizawà

    出版 2006
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  4. 4
    Effect of Aerobic Exercise on Plasma Adiponectin Levels and Insulin Resistance in Type 2 Diabetes

    Effect of Aerobic Exercise on Plasma Adiponectin Levels and Insulin Resistance in Type 2 Diabetes 由 Hisayo Yokoyama, Masanori Emoto, Takahiro Araki, Shigehiko Fujiwara, Koka Motoyama, Tomoaki Morioka, Hidenori Koyama, Tetsuo Shoji, Yasuhisa Okuno, Yoshiki Nishizawà

    出版 2004
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

    Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study 由 Satoshi Motoya, Kenji Watanabe, Haruhiko Ogata, Takanori Kanai∥, Toshiyuki Matsui, Yasuo Suzuki, Mitsuhiro Shikamura, Kenkichi Sugiura, Kazunori Oda, Tetsuharu Hori, Takahiro Araki, Mamoru Watanabe, Toshifumi Hibi∥

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Effects of vedolizumab in Japanese patients with Crohn’s disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses

    Effects of vedolizumab in Japanese patients with Crohn’s disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses 由 Kenji Watanabe, Satoshi Motoya, Haruhiko Ogata, Takanori Kanai∥, Toshiyuki Matsui, Yasuo Suzuki, Mitsuhiro Shikamura, Kenkichi Sugiura, Kazunori Oda, Tetsuharu Hori, Takahiro Araki, Mamoru Watanabe, Toshifumi Hibi∥

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: